Transcription of Public Assessment Report Decentralised Procedure
{{id}} {{{paragraph}}}
Example: quiz answers
Public Assessment Report Decentralised Procedure
Public Assessment Report Decentralised Procedure Ghemaxan 10,000 IU (100 mg)/1 mL solution for injection in pre- filled syringes Ghemaxan 15,000 IU (150 mg)/1 mL solution for injection in pre- filled syringes Ghemaxan 2,000 IU (20 mg) mL solution for injection in pre- filled syringes Ghemaxan 4,000 IU (40 mg) mL solution for injection in pre- filled syringes Ghemaxan 6,000 IU (60 mg) mL solution for injection in pre- filled syringes Ghemaxan 8,000 IU (80 mg) mL solution for injection in pre- filled syringes Ghemaxan 12,000 IU (120 mg) mL solution for injection in pre- filled syringes (Enoxaparin sodium) Procedure No: UK/H/5798/001-007/DC UK Licence No: PL 04465/0009-10 & 0014-18 Chemi PAR: Ghemaxan 100 , 150 ml, 20 , 40 ml, 60 ml, 80 ml & 120 ml solution for injection in pre- filled syringe UK/5798/001-007/DC 2 LAY SUMMARY Ghemaxan 10,000 IU (100 mg)/1 mL solution for injection in pre- filled syringes Ghemaxan 15,000 IU (150 mg)/1 mL solution for injection in pre- filled syringes Ghemax
Public Assessment Report Decentralised Procedure Ghemaxan 10,000 IU (100 mg)/1 mL solution for injection in pre-filled syringes Ghemaxan 15,000 IU (150 mg)/1 mL solution for injection in pre-filled
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: